This inventor holds 1 USPTO granted patent and 1 published patent application, plus 2 CIPO patents and 3 EPO patents. Top assignee: Streck, Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: The Innovations of Kate Chao-Wei Chen
Introduction
Kate Chao-Wei Chen is an accomplished inventor based in Indianapolis, IN (US). He has made significant contributions to the field of medical technology, particularly in the preservation of fetal nucleic acids. His innovative approach has the potential to enhance prenatal testing and diagnostics.
Latest Patents
Kate Chao-Wei Chen holds a patent for the "Preservation of fetal nucleic acids in maternal plasma." This method involves treating a sample of maternal blood to reduce cell lysis and the activity of deoxyribonuclease (DNase) and ribonuclease (RNase). The treatment increases the amount of fetal nucleic acids that can be identified and tested while maintaining their structure and integrity. He has 1 patent to his name.
Career Highlights
Kate Chao-Wei Chen is currently employed at Streck, Inc., where he continues to work on innovative solutions in the medical field. His expertise and dedication have made him a valuable asset to the company.
Collaborations
He collaborates with M Rohan Fernando, who is also involved in advancing medical technologies. Their partnership aims to push the boundaries of what is possible in prenatal diagnostics.
Conclusion
Kate Chao-Wei Chen's work exemplifies the spirit of innovation in the medical technology sector. His contributions are paving the way for improved prenatal care and diagnostics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile